FDA Efficacy Recommendations Vary for Hypogonadotropic Hypogonadism Drugs
This article, written by Meg Egan Auderset at Clarivate Analytics, describes how the new draft industry guidance from the US…
This article, written by Meg Egan Auderset at Clarivate Analytics, describes how the new draft industry guidance from the US…
A number of trends (both in science and on the regulatory front) bode well for the development and availability of…
The Russian MoH approved 158 new clinical trials of all types including local and bioequivalence studies during Q3 2017, demonstrating…
The key aim of the new EU Clinical Trial Regulation, which is currently planned for implementation in mid-2019, is to…
The age of paediatric melanoma used to be a theoretical discussion, but has become a real-life challenge due to arbitrary…
There has been a renewed interest in clinical trials of drugs to treat early Alzheimer’s disease, owing partially to recent…
The Australian clinical trials landscape has developed considerably over recent years with over 1000 new clinical trials commencing each year…
Following on from the last article featured by Svetlana Zavidova from the Association of Clinical Trials Organizations (ACTO) in the…
Clinical research is a rapidly evolving and dynamic environment and the sector is undergoing significant changes on a number of…
Conducting a clinical trial is a huge and complex undertaking, and there are, more often than not, challenges. And in…